Explore
Search ClinicalTrials.gov
Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.
Results for “breast cancer”
- Study of Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy for HR+/HER2- Locally Recurrent Inoperable or Metastatic Breast Cancer (MK-3475-B49/KEYNOTE-B49)Active Not Recruiting
Sponsor: Merck Sharp & Dohme LLC
Breast Neoplasms
United States, Argentina, Australia, Austria, Brazil +26 more
- 4:3 Intermittent Fasting Intervention in Adults With Breast Cancer and Overweight or ObesityActive Not Recruiting
Sponsor: University of Colorado, Denver
Breast Cancer
United States
- Endocrine Therapy With Abemaciclib or Chemotherapy as Initial Metastatic Treatment in ER+/HER2- Breast CancerActive Not Recruiting
Sponsor: UNICANCER
Cancer Metastatic
France
Sponsor: Pfizer
Advanced Breast Cancer · Metastatic Breast Cancer (HR+/ HER2-) · Colorectal Cancer · Metastatic Colorectal Adenocarcinoma
United States
- Inspiratory Muscle Training in Obese Breast Cancer SurvivorsActive Not Recruiting
Sponsor: Ohio State University Comprehensive Cancer Center
Cancer Survivors · Obesity · Breast Cancer
United States
- An Investigational Surgical Procedure (Vascularized Lymph Node Transfer) in Reducing the Risk of Lymphedema in Patients With Breast Cancer Undergoing Breast ReconstructionActive Not Recruiting
Sponsor: M.D. Anderson Cancer Center
Breast Carcinoma
United States
Sponsor: Wake Forest University Health Sciences
Breast Cancer · Cancer Distress
United States
Sponsor: Duke University
HER2+ Metastatic Breast Cancer
United States
Sponsor: National Cancer Institute (NCI)
Prostate Cancer · Breast Cancer · Colon Cancer · Lung Cancer
United States
Sponsor: Fred Hutchinson Cancer Center
Anatomic Stage IV Breast Cancer AJCC v8 · Clinical Stage IV Cutaneous Melanoma AJCC v8 · Locally Advanced Cutaneous Melanoma · Locally Advanced Mucosal Melanoma
United States
- Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial)Active Not Recruiting
Sponsor: National Cancer Institute (NCI)
Breast Adenocarcinoma · Hormone Receptor Positive · Stage IA Breast Cancer AJCC v7 · Stage IB Breast Cancer AJCC v7
United States, Australia, Canada, Ireland, New Zealand +3 more
Sponsor: Riga Stradins University
Breast Cancer
Latvia
- Breast Lump Clipping Methods ComparisonActive Not Recruiting
Sponsor: University of Faisalabad
Breast Neoplasms
Pakistan
- MRI-Driven Precision Typing and Response Prediction in Luminal Breast CancerActive Not Recruiting
Sponsor: Fudan University
HR Positive/HER-2 Negative Breast Cancer
China
Sponsor: Duke Street Bio Ltd
Advanced Cancers (Breast, Ovarian, mCRPC, Pancreatic Ductal Adenocarcinoma (PDAC), Brain Mets) With Specific Mutations (Homologous Recombination Deficiency)
United States, France, Hungary, Poland, Spain
- Serratus Posterior Superior Intercostal Plane Block for Postoperative Analgesia in MastectomyRecruiting
Sponsor: Saglik Bilimleri Universitesi Gazi Yasargil Training and Research Hospital
Breast Cancer
Turkey (Türkiye)
- Rising ctDNA to Tailor Endocrine Therapy Switch in Patients With ER+/HER2- Metastatic Breast Cancer.Not Yet Recruiting
Sponsor: UNICANCER
Metastatic Invasive Breast Cancer
Sponsor: BioNTech SE
Locally Advanced Breast Cancer · Unresectable Breast Carcinoma · Metastatic Breast Cancer
United States, Australia, Canada, China, France +6 more
- Safety and Efficacy Analysis of an Antibody Associated With a Chemotherapy for Patients With a Triple Negative Metastatic Breast CancerActive Not Recruiting
Sponsor: UNICANCER
Triple Negative Breast Cancer · Metastatic Breast Cancer
France
- MRI Characterization of Mammographically Detected DCISActive Not Recruiting
Sponsor: University of Washington
Breast Cancer, Stage 0
United States
- Wearable Ultrasound Patch for Breast ImagingNot Yet Recruiting
Sponsor: Massachusetts General Hospital
Breast Cancer · Breast Abnormalities · Breast Lesion · Breast Asymmetry
United States
- ATEMPT 2.0: Adjuvant T-DM1 vs THRecruiting
Sponsor: Dana-Farber Cancer Institute
Breast Cancer · HER2-positive Breast Cancer
United States
Sponsor: Context Therapeutics Inc.
Breast Cancer
United States
Sponsor: National Cancer Institute (NCI)
Advanced Malignant Solid Neoplasm · Metastatic Malignant Solid Neoplasm · Refractory Malignant Solid Neoplasm · Triple-Negative Breast Carcinoma
United States
Sponsor: University Hospitals Bristol and Weston NHS Foundation Trust
HER2 Negative Metastatic Breast Cancer
United Kingdom